Trial Profile
A Study to Evaluate the Potential Drug-Drug Interaction Between Darunavir and Danoprevir When Administered Together With Low-Dose Ritonavir in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jun 2016
Price :
$35
*
At a glance
- Drugs Danoprevir (Primary) ; Darunavir (Primary) ; Ritonavir
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors Roche
- 01 May 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 18 Apr 2012 Actual initiation date (February 2012) and actual patient no 40 added as reported by ClinicalTrials.gov.
- 18 Apr 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.